
Nexyra helps researchers uncover disease markers and design therapies faster by turning complex omics data into clear insights. It uses multi-omics integration and artificial intelligence to analyze transcriptomics, metabolomics, proteomics, and epigenomics data, delivering biomarker discovery, target identification, and predictive modeling. The platform supports preclinical design and integrated clinical and physiological analytics for translational research. As a SaaS offering with research services, Nexyra collaborates with hospitals, biotech firms, and pharma companies to advance precision medicine.

Nexyra helps researchers uncover disease markers and design therapies faster by turning complex omics data into clear insights. It uses multi-omics integration and artificial intelligence to analyze transcriptomics, metabolomics, proteomics, and epigenomics data, delivering biomarker discovery, target identification, and predictive modeling. The platform supports preclinical design and integrated clinical and physiological analytics for translational research. As a SaaS offering with research services, Nexyra collaborates with hospitals, biotech firms, and pharma companies to advance precision medicine.